ASX:VHTVolpara Health Tech Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Volpara Health Tech Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add A$1.33 -0.02 (-1.48 %) (As of 05/13/2020) Add Compare Share Today's RangeA$1.32Now: A$1.33▼A$1.3650-Day RangeA$1.07MA: A$1.31▼A$1.5452-Week RangeA$0.79Now: A$1.33▼A$2.17Volume434,964 shsAverage VolumeN/AMarket Capitalization$290.02 millionP/E RatioN/ADividend YieldN/ABetaN/A ProfileAdvanced ChartCompetitorsInsider TradesHeadlinesOptions Chain Volpara Health Technologies Limited provides breast imaging analytics and analysis products for the early detection of breast cancer in the medical device software industry. The company offers VolparaEnterprise software, a cloud based breast imaging analytics platform that delivers real-time quality assurance and performance monitoring solutions; and VolparaDensity software, which provides volumetric breast density measurements. It also offers VolparaDose that computes woman's personal X-ray dose based on specific breast density; VolparaPressure that computes the compression pressure applied to the breast during a mammogram; and VolparaPositioning that automatically assesses the positioning of the patient, as well as VolparaServer products. The company operates in the Asia Pacific, Europe, the Middle East, Africa, the United States, and Canada. The company was formerly known as matakina Technology Ltd. Volpara Health Technologies Limited was founded in 2009 and is based in Wellington, New Zealand.Read More Beat the Market (BTM) Rank™ 0.0 Analyst's Opinion Consensus RatingThere is not enough analysis data for Volpara Health Tech. Previous Next 2.6 Community Rank Outperform VotesVolpara Health Tech has received 10 “outperform” votes. (Add your “outperform” vote.)Underperform VotesVolpara Health Tech has received 9 “underperform” votes. (Add your “underperform” vote.)Community SentimentVolpara Health Tech has received 52.63% “outperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about Volpara Health Tech and other stocks. Vote “Outperform” if you believe VHT will outperform the S&P 500 over the long term. Vote “Underperform” if you believe VHT will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 0.0 Dividend Strength Dividend YieldVolpara Health Tech does not currently pay a dividend.Dividend GrowthVolpara Health Tech does not have a long track record of dividend growth. Previous Next 3.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Volpara Health Tech insiders have bought more of their company's stock than they have sold. Specifically, they have bought A$29,999.00 in company stock and sold A$0.00 in company stock. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for Volpara Health Tech are expected to grow in the coming year, from A($0.06) to A$0.00 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Volpara Health Tech is -31.67, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Volpara Health Tech is -31.67, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioVolpara Health Tech has a P/B Ratio of 17.05. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Previous Next Analyst Opinion: 0.0Community Rank: 2.6Dividend Strength: 0.0Insider Behavior: 3.0Valuation: 0.6 5 -4 -3 -2 -1 -Overall Beat the Market Rank™1.25 out of 5 stars Industry, Sector and Symbol Stock Exchange ASX Industry Diagnostics & Research Sub-IndustryN/A SectorMedical Current SymbolASX:VHT Previous Symbol CUSIPN/A CIKN/A Webvolparasolutions.com PhoneN/ADebt Debt-to-Equity Ratio5.87 Current Ratio3.58 Quick Ratio3.56Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueA$0.08 per share Price / Book17.05Profitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous EmployeesN/A Outstanding Shares218,062,000Market Cap$290.02 million Next Earnings DateN/A OptionableOptionable Receive VHT News and Ratings via Email Sign-up to receive the latest news and ratings for VHT and its competitors with MarketBeat's FREE daily newsletter. Volpara Health Tech (ASX:VHT) Frequently Asked Questions How has Volpara Health Tech's stock been impacted by COVID-19 (Coronavirus)? Volpara Health Tech's stock was trading at A$1.14 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, VHT shares have increased by 16.7% and is now trading at A$1.33. View which stocks have been most impacted by Coronavirus. Has Volpara Health Tech been receiving favorable news coverage? Media stories about VHT stock have been trending somewhat negative this week, according to InfoTrie. The research firm identifies positive and negative press coverage by analyzing more than six thousand blog and news sources. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Volpara Health Tech earned a daily sentiment score of -1.0 on InfoTrie's scale. They also assigned news stories about the company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an impact on the company's share price in the near term. View the latest news aboutVolpara Health Tech. Who are some of Volpara Health Tech's key competitors? Some companies that are related to Volpara Health Tech include Integral Diagnostics (IDX), Profound Medical (PRN), Renalytix Ai (RENX), Akumin (AKU), Exagen (XGN), Yourgene Health (YGEN), Senseonics (SENS), Palatin Technologies (PTN), MaxCyte (MXCT), Oncosil Medical (OSL), Lexagene (LXG), Oncimmune (ONC), Genedrive (GDR), SQI Diagnostics (SQD) and BARD1 Life Sciences (BD1). View all competitors. What other stocks do shareholders of Volpara Health Tech own? Based on aggregate information from My MarketBeat watchlists, some companies that other Volpara Health Tech investors own include Sabre Resources (SBR), Webjet (WEB), South32 (S32), Nearmap (NEA), Aristocrat Leisure (ALL) and Auscann Group (AC8). Who are Volpara Health Tech's key executives? Volpara Health Tech's management team includes the following people: Dr. Ralph Highnam, CEO, Chief Scientist, Exec. Director & Member of Scientific BoardMr. Craig Hadfield, CFO & Joint Company Sec.Mr. David Murray Ph.D., Chief Technology OfficerMr. Mark Koeniguer, Chief Commercial Officer & Pres of USAMr. Julian Marshall, Chief Product Officer What is Volpara Health Tech's stock symbol? Volpara Health Tech trades on the ASX under the ticker symbol "VHT." What is Volpara Health Tech's stock price today? One share of VHT stock can currently be purchased for approximately A$1.33. How big of a company is Volpara Health Tech? Volpara Health Tech has a market capitalization of $290.02 million. What is Volpara Health Tech's official website? The official website for Volpara Health Tech is volparasolutions.com. This page was last updated on 6/4/2020 by MarketBeat.com Staff
